The synthesis of multivalent systems based on hexakis-adducts of [60]fullerene employing a biocompatible copper-free click chemistry strategy has been accomplished. A symmetric hexakisadduct of fullerene bearing 12 maleimide units 3 is reported and it has been employed to carry out the thiol-maleimide Michael addition. To achieve orthogonal click addition, an asymmetric derivative bearing one maleimide and ten cyclooctynes has been synthesized. The sequential and one-pot transformations of the two clickable groups have been explored, finding the best results in the case of the one-pot experiment. This route has been used to obtain a biocompatible hexakisadduct appended with two different biomolecules, carbohydrates and amino acids.
INTRODUCTION
Multivalency has a crucial role in many biological processes, such as cell-cell, cell adhesion or cell-virus interactions. [1] [2] [3] It may be described as a strategy to achieve strong non-covalent interactions through multiple otherwise weak interactions between ligands and receptors. It is strongly related with biomolecular recognition where the resulting global interaction is stronger than the sum of the interactions of a monovalent ligand. Different supramolecular processes as chelation, clustering, subsite rebinding or statistical rebinding seem to be involved in the multivalent effect giving rise to stronger and highly selective recognition events. 2 Hence, in the last years there has been an interest in the formation of multivalent systems for the presentation of ligands to different receptors. 3 For the achievement of this goal, different platforms have been employed that allow the formation of multivalent clusters, 4 such as dendrimers, 5, 6 nanoparticles, 7 aromatics, 8 polymers, 9 liposomes, 10 graphene, 11,12 nanotubes 13, 14 or fullerenes 15-17 among others.
Their remarkable features make [60]fullerene hexakis-adducts suitable platforms for the construction of multivalent systems, including their monodisperse globular disposition of the ligands, due to a T h octahedral symmetry. 18 It is important to note that size and shape are important issues to address in the presentation of multivalent systems. Actually, they can even play a most significant role than multivalency itself. In this regard, the previously synthesized polyvalent bacteriophage-based glycodendrinanoparticle displaying 1620 copies of mannose on its surface 19 exhibited around 18 times less efficiency (IC50 value) than a tridecafullerene having 120 mannoses. 15 The synthesis of these derivatives was first reported by Hirsch 20 and later modified by Sun 21 and is carried out in one-step by the Bingel addition of the corresponding malonates. This route, however, is limited by the steric effects of the functionalized malonates, usually proceeding with moderate to low yields. To circumvent this limitation, a two-step procedure is usually carried out, functionalizing in the first step the C 60 surface with simple malonates which are lately post-functionalized in the second step.
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Nierengarten and our own group have developed a two-step click-chemistry approach to obtain complex hexakis-adducts. [27] [28] [29] In the first step, an alkyne or azide functionalized malonate is added to the C 60 core, obtaining the hexakis-adduct which is then chemically modified by the Cu(I)-catalyzed alkyne azide 1,3-dipolar cycloaddition (CuAAC). This methodology has led to derivatives for applications in different areas, such as materials science 30, 31 and especially for biological applications. [32] [33] [34] [35] However, the employ of copper is a serious drawback for the biocompatibility of the obtained products. Generally, an additional purification step is needed to eliminate the residual copper. Moreover, when the obtained molecules have copper chelating groups, a small amount of this metal remains chelated to the molecule after several purification steps. 36 This is more noticeable in the case of multivalent systems in which there are many of those chelating groups which, in some cases, could affect to the click reaction, lowering the yields and even, in some cases, inhibiting the reaction.
As previously observed for the cyclooctyne appended hexakis-adduct, 37 direct addition of the corresponding malonate by Bingel reaction under the conditions reported by Sun yielded a complex mixture of different products owing to bromination of the maleimide unit.
Therefore, we followed a three steps strategy involving formation of the hexakis-adduct with protected alcohols 1a, 37 deprotection to yield 1b and esterification with 3-maleimidepropionic acid (2) in the presence of DCC and DMAP (Scheme 1). Purification of the hexakis-adduct 3 was developed by size-exclusion chromatography using Sephadex (DCM:MeOH 1:1). Employing the thiol-maleimide click reaction, we proved the platform for the conjugation of different thiols, as non-polar 1-octanethiol (5a), polar 2-(2-(2-mercaptoethoxy)ethoxy)ethan-1-ol (5b) and the protected amino acid N-acetyl-L-cysteine methyl ester (5c) (Scheme 2). A mixture of 3 (1 eq) and the corresponding thiol (1.5 eqs per maleimide unit) in DMF was kept at room temperature for 30 min. After purification using Sephadex, derivatives 5a-c were obtained in excellent yields.
The structure of compounds 5a-c was confirmed by 1 H NMR and 13 C NMR spectroscopy.
DEPT, COSY and HSQC experiments were carried out for all new compounds synthesized to confirm the proposed structures (see ESI). The 1 H NMR spectra of these conjugates clearly show completion of the addition of the thiols by the disappearance of the characteristic signal of the olefinic protons of the maleimide at δ 6.71. The addition of the thiol generates a new asymmetric centre per maleimide unit, leading to a complex mixture of diastereoisomers owing to the multivalent presentation of the systems. However, the high symmetry of these hexakis-adducts provides NMR spectra simpler than those we can expect. For 5a and 5b, the signals for the proton of the new stereogenic centre are indistinguishable for the two possible isomers and only one signal is observed at 3.72 and 3.94 ppm, respectively. For compound 5c, on the other side, a diastereomeric mixture per maleimide unit is formed upon addition of the thiol, and therefore the signals of the cysteine and the maleimide moieties appear duplicated (see ESI). 13 C NMR spectra of 5a-c also confirm the structure showing the presence of only two signals for the sp 2 carbons of [60]fullerene at ∼ 145 and 141 ppm and the loss of the signal of the olefinic carbons of the maleimide observed at ∼ 134 ppm ( Figure   1 ).
Once we had prepared the symmetric adduct 3, we were interested in obtaining an asymmetric derivative for the simultaneous addition of different addends to the C 60 scaffold.
To improve the biocompatibility of the resulted systems, we thought of an orthogonal copper-free click reaction. Thus, maleimide and cyclooctyne units were introduced in the same molecule by following the synthetic pathway depicted in Scheme 3. Monoadduct 8 was first synthesized under typical Bingel addition conditions, adding malonate 7 (1 eq), I 2 (3.5 eqs) and DBU (2.5 eqs) to a solution of C 60 (2 eqs). Formation of the asymmetric hexakisadduct was carried out by addition of the malonate 9 with orthogonal protection of the alcohol group (10 eqs) in the presence of a large excess of CBr 4 (80 eqs) and DBU (20 eqs).
Hydrogenation at atmospheric pressure of compound 10 led to quantitative deprotection of the benzyl groups to yield compound 11, which was submitted to esterification with the cyclooctyne carboxylic acid 12 in the presence of DCC and DMAP. The deprotection of the TBDPS was achieved by the HF/pyridine complex in the presence of AcOH and a final esterification with maleimide carboxylic acid 2 yielded compound 15.
Characterization by 1 H NMR and 13 C NMR of all derivatives confirmed the proposed structures. Even for the asymmetric hexakis-adducts of C 60 10-15, only two signals were observed in the 13 C NMR spectrum for the 48 sp 2 carbons of the fullerene core in the compounds, showing the high local symmetry of these derivatives, as previously reported (Figure 2) . 29, 39, 40 Then, the reactivity of compound 15 was explored either in a stepwise sequence (routes A and B, Scheme 4) or in a one-pot process (route C, Scheme 4)). First, the SPAAC addition of 2-(2-(2-azidoethoxy)ethoxy)ethan-1-ol to the cyclooctyne moieties was carried out. The previously reported conditions for this addition (DMSO, MW, 50°C) were avoided to prevent reaction of the azide with the maleimide, which can take place at high temperature. Thus, the SPAAC reaction was accomplished in DMSO at room temperature overnight and led quantitatively to compound 16 after size-exclusion chromatography with Sephadex LH-20. The signals corresponding to the two carbons of the triazole rings were also duplicated, appearing at δ ∼ 145 and 135 for the major isomer and δ ∼ 144 and 133 for the minor isomer.
Importantly, the signals of the olefinic carbons of the maleimide unit were also present at δ ∼ 134, which confirms the exclusive functionalization of the cyclooctyne moieties under these conditions ( Figure 2 ). Treatment of compound 16 with 1-octanethiol in DMF at room temperature, under the same conditions employed for the synthesis of 5a-c, did not lead to the quantitative conversion to 17a, as the signal corresponding to the maleimide protons was present in the 1 H NMR spectrum. Therefore, temperature and time reaction were increased (24 h, 50ºC) and an excess of thiol was added (10 eqs). Even under these conditions, the maleimide unit remained unreacted. In conclusion, route C seems to be the more adequate to the preparation of derivatives bearing two different addends around the C 60 scaffold.
As a proof of concept to check the scope of this methodology with more complex derivatives, we synthesized compound 17b, in which an amino acid and ten carbohydrate units have been clicked to the fullerene scaffold using the route C. A solution of compound 15 in DMF was treated with the cysteine derivative 4c and, after 30 min, the azide mannose 19 was added and the mixture submitted to MW irradiation at 50°C for 30 min. After purification with G- 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 interesting addends, as carbohydrates and amino acids, allowing to get mixed adducts with these two types of compounds. Moreover, the two processes are carried out in the absence of copper as catalyst, which is a key point for the biocompatibility of the new conjugates. This kind of derivatives could be of interest for several biological applications for which carbohydrates should be added as recognition motifs to address and facilitate the internalization of the appropriate epitope depending on the biological target.
EXPERIMENTAL SECTION
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Synthesis and Characterization

Thiol-maleimide conjugation
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mmol) was added dropwise to a solution of 4-((tert-butyldiphenylsilyl)oxy)butan-1-ol
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